Trials & Tribulations Unlocking the future of precision medicine:The untapped power of RNA May 23, 2025Vol.51 No.20By Eric Lefkofsky and Norman E. "Ned" Sharpless
A new AI tool enables speedy use of ASCO guidelines, eliminating typical errors May 23, 2025Vol.51 No.20By Claire Marie Porter
Kennedy’s claims notwithstanding, NCI clinical trials are delayed, enrollments reducedNCI’s Steven A. Rosenberg: “Almost all patients are getting delayed by about a month, but then again, we’re turning away more patients.” May 16, 2025Vol.51 No.19By Jacquelyn Cobb
FreeTrials & Tribulations Working with cancer: Rethinking long-term health for working-age adult cancer survivors May 09, 2025Vol.51 No.18By Susan A. Speckhart, Rebecca Miksad and Lidia Schapira
Neoadjuvant dostarlimab averts brutal surgery in 80% of patients with dMMR solid tumors May 02, 2025Vol.51 No.17By Jacquelyn Cobb
Free Kelly Spill opted for dostarlimab trial, avoiding rectal cancer treatment that would leave her infertileSix years later, she is well—and pregnant with her third child May 02, 2025Vol.51 No.17By Jacquelyn Cobb
TIL + pembro regimen achieves 24% response rate in solid epithelial tumors, marking a step forward in immunotherapy research April 18, 2025Vol.51 No.15By Jacquelyn Cobb
Only half of adolescents and young adults with cancer get fertility counseling before treatmentOncofertility consult is an oft-overlooked standard of care April 11, 2025Vol.51 No.14By Claire Marie Porter
Survey reveals most Americans are uninformed about HPVA vaccine can prevent cancer—most people don’t take it March 07, 2025Vol.51 No.09By Claire Marie Porter
FreeTrials & Tribulations The new therapeutic imperative in cancer management: Sequence, biosimulate, treat March 07, 2025Vol.51 No.09By Michael P. Castro
